Editor's Note
The Food and Drug Administration (FDA) on August 11 classified the recall by Becton Dickinson (BD) of its Intraosseous Infusion System, which includes Intraosseous Needle Set Kits, Intraosseous Manual Driver Kits, and Intraosseous Powered Drivers, as Class I, the most serious.
The recall was initiated for three separate issues:
To date, there have been 37 complaints, no serious injuries, and no deaths associated with these issues. Distribution dates were January 20, 2020, to May 5, 2022.
Read More >>The kind of Navy-taught leadership Brian Dawson, MSN, RN-BC, CNOR,…
Remote surgery has come a long way since the first-ever…
Patient safety and regulatory compliance demand thoroughly vetting those tasked…